eHealthInfoLine Announces Consumer Health News Monitoring Program
The latest health and medical news usually escapes the public's attention because major news outlets choose to focus on other topics. Because of this, eHealthInfoLine is upgrading its monitoring of health related news, from scientific breakthroughs and new drug approvals to lawsuits and medical warnings. Headlines will be posted on the eHealthInfoLine home page, making them easy to find and will be sent to site users who sign up for a free newsletter.
Recently posted topics pertain to lipo dissolve - also known as phosphatidylcholine-based injections and injection lipolysis - which the Food and Drug Administration warned recently are "unapproved drugs for unapproved uses"; a new malignant melanoma cancer drug called STA-4783 that may wipe out tumors; and headlines related to recent advances on the worldwide fight against malaria.
Healthcare consumers who visit eHealthInfoLine will find new headlines every week thanks to a team of dedicated site editors who monitor health journals and medical news sources every week. Every news release can be found either on the eHealthInfoLine home page or within topically related areas of the website, such as Fat Loss, Hair Loss Treatment, or Skin Cancers. Healthcare job seekers may even find new information pertaining to jobs in the medical field.
At times a hot topic may hit the radar screen, with quickly evolving headlines. For example, in the fall of 2007 there has been a controversy around the drugs used in a popular aesthetic fat melting treatment known as lipodissolve. Don't confuse it with liposuction, which uses a vacuum to remove liters of fat from the body. Lipo-dissolve injections results in the removal of small deposits of fat from areas of the body such as the belly, under the chin, love handles, and thighs. The treatments are non-surgical, with the primary side effects being soreness and redness in the injection areas sites. One estimate says that nearly 100,000 lipodissolve treatments have been given in the United States and abroad to date.
The Food and Drug Administration recently issued a lipodissolve consumer alert, saying that the typically used drugs, phosphatidylcholine and sodium deoxycholate, are unapproved drugs for unapproved uses. So will this warning slow the upward trend? Time will tell. There have been no major studies on the safety and efficacy of lipodissolve yet.
This is one example of the types of news covered on eHealthInfoline. When the FDA sends out a warning or issues an approval, the website will promote the news. Major metropolitan newspapers and news shows, and especially small local news outlets, simply don't have enough space or airtime for health news. Those limits don't exist on the Internet.
Unfortunately, most people know someone who has fought or is fighting some form of cancer. The good news is that researchers are always testing new cancer drugs, and the FDA frequently announces new drug approvals. Breakthroughs are announced all the time. For example, malignant melanoma is a deadly form of skin cancer; few drugs are available to fight it. If it's not caught and treatet very early, the survival rate is not good. STA-4783, and oncology drug developed by Synta Pharmaceuticals Corp., has shown promising results in treating malignant melanoma and the FDA is giving it fast track status. One clinical trial in patients with stage IV metastatic malignant melanoma, treatment with STA-4783 plus paclitaxel helped stop the cancer's progression. STA-4783 has shown to actually kill cancer cells, which gives doctors hope that it can cure people instead of just extending lives for a few months.
The best way to stay up on current medical news and breakthroughs is to bookmark the eHealthInfoLine home page and return to it frequently.
BACK TO
eHealthInfoLine >>>